» Articles » PMID: 22026626

Design Properties of Hydrogel Tissue-engineering Scaffolds

Overview
Specialties Pharmacology
Radiology
Date 2011 Oct 27
PMID 22026626
Citations 375
Authors
Affiliations
Soon will be listed here.
Abstract

This article summarizes the recent progress in the design and synthesis of hydrogels as tissue-engineering scaffolds. Hydrogels are attractive scaffolding materials owing to their highly swollen network structure, ability to encapsulate cells and bioactive molecules, and efficient mass transfer. Various polymers, including natural, synthetic and natural/synthetic hybrid polymers, have been used to make hydrogels via chemical or physical crosslinking. Recently, bioactive synthetic hydrogels have emerged as promising scaffolds because they can provide molecularly tailored biofunctions and adjustable mechanical properties, as well as an extracellular matrix-like microenvironment for cell growth and tissue formation. This article addresses various strategies that have been explored to design synthetic hydrogels with extracellular matrix-mimetic bioactive properties, such as cell adhesion, proteolytic degradation and growth factor-binding.

Citing Articles

Bioprinted hydrogels in bone regeneration: a bibliometric analysis.

Zhang H, Li X, Jia Z, Jiao K, Liu C, Deng Z Front Pharmacol. 2025; 16:1532629.

PMID: 39963238 PMC: 11830744. DOI: 10.3389/fphar.2025.1532629.


Peptide hydrogel-drug conjugates for tailored disease treatment.

Cauwenbergh T, Ballet S, Martin C Mater Today Bio. 2025; 31:101423.

PMID: 39944533 PMC: 11815290. DOI: 10.1016/j.mtbio.2024.101423.


Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.

Wang Y, Hou Y, Hao T, Garcia-Contreras M, Li G, Cretoiu D Biomater Transl. 2025; 5(4):337-354.

PMID: 39872935 PMC: 11764187. DOI: 10.12336/biomatertransl.2024.04.002.


Three-Dimensional Printing/Bioprinting and Cellular Therapies for Regenerative Medicine: Current Advances.

Sousa A, Alvites R, Lopes B, Sousa P, Moreira A, Coelho A J Funct Biomater. 2025; 16(1).

PMID: 39852584 PMC: 11765675. DOI: 10.3390/jfb16010028.


Modeling intratumor heterogeneity in breast cancer.

McDonough E, Barroso M, Ginty F, Corr D Biofabrication. 2024; 17(1.

PMID: 39642392 PMC: 11740194. DOI: 10.1088/1758-5090/ad9b50.


References
1.
Tsur-Gang O, Ruvinov E, Landa N, Holbova R, Feinberg M, Leor J . The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials. 2008; 30(2):189-95. DOI: 10.1016/j.biomaterials.2008.09.018. View

2.
Li Q, Wang J, Shahani S, Sun D, Sharma B, Elisseeff J . Biodegradable and photocrosslinkable polyphosphoester hydrogel. Biomaterials. 2005; 27(7):1027-34. PMC: 2376802. DOI: 10.1016/j.biomaterials.2005.07.019. View

3.
Phelps E, Landazuri N, Thule P, Taylor W, Garcia A . Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci U S A. 2010; 107(8):3323-8. PMC: 2840448. DOI: 10.1073/pnas.0905447107. View

4.
Shu X, Ghosh K, Liu Y, Palumbo F, Luo Y, Clark R . Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res A. 2004; 68(2):365-75. DOI: 10.1002/jbm.a.20002. View

5.
Freudenberg U, Hermann A, Welzel P, Stirl K, Schwarz S, Grimmer M . A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials. 2009; 30(28):5049-60. DOI: 10.1016/j.biomaterials.2009.06.002. View